Myths vs facts: TCF7L2 and weight loss

Myths vs facts: TCF7L2 and weight loss Myth: A TCF7L2 gene variant determines whether you can lose weight successfully. Fact: TCF7L2 (transcription factor 7-like 2) is strongly associated with type 2 diabetes risk (GWAS, rs7903146). Some studies suggest carriers of the risk variant may respond differently to low-carb or fat-modified diets, but effect sizes are small and inconsistent. There is insufficient evidence to give personalized diet recommendations based solely on this gene. Weight loss is primarily driven by calorie balance, lifestyle, and environmental factors. The genetic testing industry often overclaims. Caution: No direct supplement or drug is proven for TCF7L2-based weight loss. Evidence: human-GWAS/moderate. Safety note: Do not start supplements or extreme diets without medical supervision.